Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4229124
Max Phase: Preclinical
Molecular Formula: C43H45N11O7
Molecular Weight: 827.90
Molecule Type: Small molecule
Associated Items:
ID: ALA4229124
Max Phase: Preclinical
Molecular Formula: C43H45N11O7
Molecular Weight: 827.90
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCn1nc(C2CC2)cc1Nc1nc(C(=O)NCCCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nc2[nH]c3cc(-c4c(C)noc4C)c(OC)cc3c12
Standard InChI: InChI=1S/C43H45N11O7/c1-5-53-32(20-28(51-53)23-12-13-23)47-38-36-25-19-31(60-4)26(34-21(2)52-61-22(34)3)18-29(25)46-37(36)49-39(50-38)41(57)45-17-8-6-7-16-44-27-11-9-10-24-35(27)43(59)54(42(24)58)30-14-15-33(55)48-40(30)56/h9-11,18-20,23,30,44H,5-8,12-17H2,1-4H3,(H,45,57)(H,48,55,56)(H2,46,47,49,50)
Standard InChI Key: XNEXUBXOTMSNMZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 827.90 | Molecular Weight (Monoisotopic): 827.3503 | AlogP: 5.64 | #Rotatable Bonds: 15 |
Polar Surface Area: 231.36 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 5 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.36 | CX Basic pKa: 4.45 | CX LogP: 3.96 | CX LogD: 3.96 |
Aromatic Rings: 6 | Heavy Atoms: 61 | QED Weighted: 0.06 | Np Likeness Score: -0.87 |
1. Zhou B, Hu J, Xu F, Chen Z, Bai L, Fernandez-Salas E, Lin M, Liu L, Yang CY, Zhao Y, McEachern D, Przybranowski S, Wen B, Sun D, Wang S.. (2018) Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression., 61 (2): [PMID:28339196] [10.1021/acs.jmedchem.6b01816] |
Source(1):